Mindfulness Based Relapse Prevention: Efficacy and Mechanisms

Completed · Phase 1/Phase 2

Conditions studied: Substance Use Disorders

In brief

The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol and other drug (AOD) use disorders in preventing AOD relapse compared to treatment as usual (TAU) offered in the community. The two cognitive-behavioral aftercare treatments are relapse prevention (RP) and Mindfulness-Based Relapse Prevention (MBRP), which integrates mindfulness meditation and RP aftercare components.

Key facts

Study ID

NCT01159535

Run by

University of Washington

People needed

286

Starts

2009-10-01

Expected to finish

2012-07-01

Last updated by the study team

2016-08-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• completion or scheduled completion (i.e., within 2 weeks) of Inpatient or Intensive Outpatient treatment
• fluency in English
• enrollment in a substance abuse aftercare program
• medical clearance by referring provider
• willingness to accept random assignment to treatment condition

You may not qualify if…

• already participated in the pilot MBRP trial conducted by this research team
• participation in the comorbid disorders or relapse prevention groups offered at partner agency
• comorbid psychosis (including schizophrenia, schizoaffective or other schizophreniform disorder)and/or dementia, acute suicidality/intent to harm others, severe cognitive impairment, and high risk of withdrawal or medical complications stemming from relapse which would require a higher level of care.

Where it is running

• Recovery Centers of King County — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.